Connor Clark & Lunn Investment Management Ltd. lifted its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 1,802.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 532,365 shares of the company's stock after acquiring an additional 504,384 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.08% of Avantor worth $13,772,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in the stock. Versant Capital Management Inc raised its stake in Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock valued at $31,000 after acquiring an additional 1,391 shares during the last quarter. UMB Bank n.a. bought a new position in Avantor in the 3rd quarter valued at approximately $49,000. Nisa Investment Advisors LLC raised its stake in shares of Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock valued at $53,000 after acquiring an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock valued at $70,000 after acquiring an additional 1,285 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on AVTR. Wells Fargo & Company dropped their price target on Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. TD Cowen upped their price objective on Avantor from $28.00 to $31.00 and gave the company a "buy" rating in a research note on Monday, July 29th. Stifel Nicolaus increased their price objective on Avantor from $27.00 to $28.00 and gave the company a "buy" rating in a report on Monday, July 29th. Robert W. Baird reduced their target price on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a report on Monday, October 28th. Finally, Barclays lowered their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research report on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $27.57.
View Our Latest Report on Avantor
Insider Activity at Avantor
In other news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. This trade represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.
Avantor Price Performance
AVTR traded up $0.46 on Friday, hitting $20.82. 4,870,458 shares of the company's stock were exchanged, compared to its average volume of 6,490,402. The stock has a market cap of $14.17 billion, a price-to-earnings ratio of 44.59, a P/E/G ratio of 2.39 and a beta of 1.35. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a fifty-two week low of $19.59 and a fifty-two week high of $28.00. The firm has a 50-day moving average price of $24.01 and a 200-day moving average price of $23.89.
About Avantor
(
Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Further Reading
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
